Gene/Protein
Disease
Symptom
Drug
Enzyme
Compound
Pivot Concepts:
Gene/Protein
Disease
Symptom
Drug
Enzyme
Compound
Target Concepts:
Gene/Protein
Disease
Symptom
Drug
Enzyme
Compound
Query: UMLS:C0043352 (
xerostomia
)
4,250
document(s) hit in 31,850,051 MEDLINE articles (0.00 seconds)
The submandibular salivary glands of non-obese diabetic (NOD) mice, a model for Sjogren's syndrome and type-1 diabetes, show an elevated level of proliferating cell nuclear antigen (PCNA), a protein involved in cell proliferation and repair of DNA damage. We reported previously that epigallocatechin-3-gallate (EGCG), the most abundant green tea catechin, normalizes the PCNA level. PCNA's activity can be regulated by the cyclin-dependent kinase inhibitor
p21
, which is also important for epithelial cell differentiation. In turn, expression of
p21
and PCNA are partially regulated by Rb phosphorylation levels. EGCG was found to modulate
p21
expression in epithelial cells, suggesting that EGCG-induced
p21
could be associated with down-regulation of PCNA in vivo. The current study examined the protein levels of
p21
and p53 (which can up-regulate
p21
) in NOD mice fed with either water or EGCG, and the effect of EGCG on
p21
and p53 in cell line models with either normal or defective Rb. In NOD mice, the
p21
level was low, and EGCG normalized it. In contrast to HSG cells with functional Rb, negligible expression of
p21
in NS-SVAC cells that lack Rb was not altered by EGCG treatment. Inhibition of p53 by siRNA demonstrated that
p21
and p53 were induced independently in HSG cells by a physiological concentration range of EGCG, suggesting p53 could be an important but not conditional factor associated with
p21
expression. In conclusion, PCNA and
p21
levels are altered inversely in the NOD model for SS and in HSG cells, and warrant further study as candidate new markers for salivary dysfunction associated with
xerostomia
. Induction of
p21
by EGCG could provide clinically useful normalization of salivary glands by promoting differentiation and reducing PCNA levels.
...
PMID:Epigallocatechin-3-gallate prevents autoimmune-associated down- regulation of p21 in salivary gland cells through a p53-independent pathway. 2432 14